Project 1 slider

Project 1

We have developed a nanotechnology-based dendritic cell vaccine (Nano-DC vaccine) to mobilize and subsequently transport antigen-specific T cells into tumor tissues. The vaccine will be effective either on its own or in combination with other immunotherapeutic agents.

More >>

Leave a Reply

Your email address will not be published. Required fields are marked *